SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001144204-11-065345
Filing Date
2011-11-16
Accepted
2011-11-16 14:26:41
Documents
2
Period of Report
2011-08-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A v240934_8ka.htm 8-K/A 27322
2 EXHIBIT 10.1 v240934_ex10-1.htm EX-10.1 14194
  Complete submission text file 0001144204-11-065345.txt   42911
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10019
Business Address 110 EAST 59TH STREET NEW YORK NY 10019 250-519-0553
BRAINSTORM CELL THERAPEUTICS INC (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 912061050 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-54365 | Film No.: 111209677
SIC: 2836 Biological Products, (No Diagnostic Substances)